The number of cases of endometrial cancer has shown a tendency to increase in recent
years. Endometrial cancer originates from the endometrium and is classified, based on the …

OBJECTIVE: This article represents a review of histologic and genetic findings in
endometriosis and describes the mechanisms whereby genetic and non-genetic factors …

Identification of biomarkers potentially provides prognostic information that can help guide
clinical decision-making. Given the relationship between estrogen exposure and …

Endometrial carcinogenesis is involved in several signaling pathways and it comprises
multiple steps. The four major signaling pathways—PI3K/AKT, Ras/Raf/MEK/ERK, WNT/β …

While endometriosis is a benign condition, the presence of endometriosis has been
associated with the development of several types of cancers, including ovarian …

Endometriosis may be a definitive risk factor for ovarian cancer, the most fatal gynecological
cancer. The ability of endometriosis to transform into malignancy, first described by Dr …

There is definitely a need for the development of new drugs for the treatment and cure of
endometrial cancer. In addition there are various new drugs or phyto-remedies under …

Systemic treatment represents the cornerstone of endometrial cancer management in
advanced, relapsed and metastatic disease, which is still characterized by poor prognosis …

For several decades, endometriosis has been suspected of playing a role in the aetiology of
ovarian cancer. The literature concerning a possible histogenesis of ovarian cancer from …

Endometriosis is a painful reproductive and immunological disease afflicting about 7-10% of
women worldwide. It is one of the most frequent benign gynaecological diseases; however …